Stocktoria
BRISTOL MYERS SQUIBB CO BMY
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1980-03-17
BRISTOL MYERS SQUIBB CO statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net margin | 14.6% | -18.5% | 17.8% | 13.7% | 15.1% |
| FCF margin | 26.7% | 28.9% | 28.1% | 25.9% | 32.8% |
| Return on assets | 7.8% | -9.7% | 8.4% | 6.5% | 6.4% |
| Return on equity | 38.1% | -54.6% | 27.2% | 20.3% | 19.4% |
| Debt / equity | 2.42× | 3.02× | 1.34× | 1.25× | 1.23× |
| Current ratio | 1.26 | 1.25 | 1.43 | 1.25 | 1.52 |
| Revenue growth | -0.2% | 7.3% | -2.5% | -0.5% | 9.1% |
Source: SEC EDGAR filings · CIK 0000014272 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.